Your shopping cart is currently empty

Synonyms: Template-Activating Factor-I, chromatin remodelling factor, Template-activating factor I, Template activating factor I, TAF-I, TAFI, TAF IBETA, TAF I, SET_HUMAN, SET translocation (myeloid leukemia-associated), SET translocation, SET nuclear oncogene, Set, Protein SET, protein phosphatase type 2A inhibitor, Phosphatase 2A inhibitor I2PP2A, PHAPII, IPP2A2, inhibitor-2 of protein phosphatase-2A, Inhibitor of GzmA-activated DNase, Inhibitor of granzyme A-activated DNase, Inhibitor of granzyme A activated DNase, IGAAD, I-2PP2A, I2PP2A, I 2PP2A, HLA-DR-associated protein II, HLA DR associated protein II, 2PP2A
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 50 μL | $296 | 7-10 days | 7-10 days | |
| 100 μL | $497 | 7-10 days | 7-10 days |
| Description | Anti-SET Antibody (3V307) is a Rabbit antibody targeting SET. Anti-SET Antibody (3V307) can be used in FCM,ICC,IF,IHC,IP,WB. |
| Synonyms | Template-Activating Factor-I, chromatin remodelling factor, Template-activating factor I, Template activating factor I, TAF-I, TAFI, TAF IBETA, TAF I, SET_HUMAN, SET translocation (myeloid leukemia-associated), SET translocation, SET nuclear oncogene, Set, Protein SET, protein phosphatase type 2A inhibitor, Phosphatase 2A inhibitor I2PP2A, PHAPII, IPP2A2, inhibitor-2 of protein phosphatase-2A, Inhibitor of GzmA-activated DNase, Inhibitor of granzyme A-activated DNase, Inhibitor of granzyme A activated DNase, IGAAD, I-2PP2A, I2PP2A, I 2PP2A, HLA-DR-associated protein II, HLA DR associated protein II, 2PP2A |
| Ig Type | IgG |
| Clone | 3V307 |
| Reactivity | Human,Mouse,Rat |
| Application | |
| Recommended Dose | WB: 1:500-2000; IHC: 1:50-200; ICC: 1:50-200; IP: 1:10-50; FCM: 1:50-100 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | Recombinant Antibody |
| Purification | ProA affinity purified |
| Appearance | Liquid |
| Formulation | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
| Research Background | Multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone chaperoning. Isoform 2 apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-induced apoptosis, GZMA cleaves SET, disrupting its binding to NME1 and releasing NME1 inhibition. Isoform 1 and isoform 2 are potent inhibitors of protein phosphatase 2A. Isoform 1 and isoform 2 inhibit EP300/CREBBP and PCAF-mediated acetylation of histones (HAT) and nucleosomes, most probably by masking the accessibility of lysines of histones to the acetylases. The predominant target for inhibition is histone H4. HAT inhibition leads to silencing of HAT-dependent transcription and prevents active demethylation of DNA. Both isoforms stimulate DNA replication of the adenovirus genome complexed with viral core proteins; however, isoform 2 specific activity is higher. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein |
| Uniprot ID |
| Molecular Weight | Theoretical: 37 kDa. |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.